Autres langues Microbix Biosystems Inc.

Actions

Temps Différé Toronto S.E. Autres places de cotation 19:40:04 13/05/2024			Varia. 5j.	Varia. 1 janv.
0,33 ^CAD	0,00%		-2,94%	-15,38%

25/04	Un collaborateur de Microbix présente un nouveau programme d'accréditation des laboratoires	CI
27/03	Transcript : Microbix Biosystems Inc. - Shareholder/Analyst Call

Microbix Schedules Release of Results for Q2 Fiscal 2024	08/05
Microbix to Present New Lab Accreditation Program at European Congress on Clinical Microbiology	25/04
Microbix Collaborator Introduces New Lab Accreditation Program	25/04
Microbix Collaborator Introduces New Lab Accreditation Program	25/04
Microbix Presenting at the 2024 Bloom Burton Conference	11/04
Microbix Announces Annual and Special Meeting Voting Results	01/04
Microbix Says Clot-Buster Drug Project Advancing	14/03
Microbix Brief: Says Clot-Buster Drug Project Advancing	14/03
Microbix’s Clot-Buster Drug Project Advances	14/03
Microbix?S Clot-Buster Drug Project Advances	14/03
Microbix Unveiling Test Controls for Head and Neck Cancer	11/03
Microbix Brief: Unveiling Test Controls for Head and Neck Cancer	11/03
Microbix Unveils Test Controls for Head and Neck Cancer	11/03
Microbix Unveils Test Controls for Head and Neck Cancer	11/03
Microbix Biosystems Inc. Unveils Test Controls for Head and Neck Cancer	11/03
Microbix Announces Issuance of Stock Options	26/02
Microbix Higher After Reporting Record Results for Q1 Fiscal 2024	14/02
Earnings Flash (MBX) MICROBIX BIOSYSTEMS Posts Q1 Revenue $8.4M	14/02
Microbix Reports Record Results for Q1 Fiscal 2024	14/02
Tranche Update on Microbix Biosystems Inc.'s Equity Buyback Plan announced on December 6, 2023.	14/02

Aucun résultat pour cette recherche